|
HS Code |
527593 |
| Product Name | Tacrine Hydrochloride |
| Chemical Formula | C13H14ClN·HCl |
| Molecular Weight | 288.18 g/mol |
| Cas Number | 1684-40-8 |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Storage Conditions | Store at 2-8°C, protected from light |
| Pharmacological Class | Cholinesterase inhibitor |
| Usage | Used in the treatment of Alzheimer’s disease |
| Synonyms | Cognex; 1,2,3,4-Tetrahydro-9-aminoacridine hydrochloride |
| Route Of Administration | Oral |
| Stability | Stable under recommended storage conditions |
| Melting Point | 255-257°C (decomposes) |
As an accredited Tacrine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Tacrine Hydrochloride is supplied in a 5 gram amber glass bottle with a tightly sealed cap, labeled with product details and safety information. |
| Shipping | Tacrine Hydrochloride is shipped in tightly sealed containers, protected from light and moisture. It is typically transported at room temperature unless specified otherwise. Adhering to regulatory guidelines for hazardous materials, proper labeling and documentation are ensured for safe handling during storage and transit to prevent contamination or degradation. |
| Storage | Tacrine Hydrochloride should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry place at 2–8°C (refrigerator temperature). Avoid exposure to excess heat and incompatible substances. Ensure proper labeling and restrict access to authorized personnel only. Follow institutional and regulatory guidelines for safe chemical storage and handling. |
Applications of Tacrine Hydrochloride in Industrial ManufacturingTacrine Hydrochloride serves as a specialized raw material primarily in regulated pharmaceutical and biotechnology sectors. Our vertically integrated production complies with stringent regulatory and quality systems to ensure consistency and traceability throughout multiple targeted downstream applications. 1. Active Pharmaceutical Ingredient (API) Synthesis for Alzheimer’s Disease TreatmentsThis material plays a crucial role in the production of cholinesterase inhibitor medications, specifically for cognitive disorder management. End-users require precise formulation and batch traceability due to tight regulatory controls. Tacrine Hydrochloride is introduced at the defined API stage before final oral dosage formulation. Producers rely on validated scale-up processes, with analytical batch verification and impurity profiling conducted at every lot transition. Finished dosages must meet bioequivalence and identity standards for market authorization in major regions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Research Chemical for Neuropharmacology ScreeningIn preclinical and academic R&D, neuroscientists use Tacrine Hydrochloride for binding studies, enzyme inhibition assays, and proof-of-concept experiments. Demand centers on high-grade, fully traceable bulk material for in vitro and in vivo model validation. Laboratories prioritize batch-to-batch consistency in analytical purity and stability, and all supply chain documentation must withstand regulatory audits. Product enters R&D workflows via solution preparation and biological assay set-ups to generate published data essential for IND filings or scientific publications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Cholinesterase Inhibitor API DerivatizationTacrine Hydrochloride functions as a chemical intermediate in the production of second-generation analogs targeting new therapeutic candidates. Downstream manufacturers customize derivative synthesis via proprietary functionalization pathways. The material’s salt form enables solubility and high-yield reactivity during alkylation, acylation, or heterocycle formation reactions. QC labs test and certify each lot for residual solvent content and specific impurity profiles before the intermediate enters scale-up pilot programs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Reference Standard for Quality Control (QC) LaboratoriesPharmaceutical QC and regulatory testing divisions employ Tacrine Hydrochloride as a certified reference standard to verify ingredient identity, assay accuracy, and impurity quantification in finished dosage products. Laboratories require documented COA (Certificate of Analysis), verified chromatographic purity, and lot-to-lot homogeneity validated against international standards. Integration typically occurs during method validation, batch release testing, or forensic product investigations, ensuring regulatory compliance for product release within approved global markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Tacrine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Tacrine Hydrochloride has long played a notable part in drug discovery, especially as an acetylcholinesterase inhibitor. We have spent years optimizing our production process to achieve material that meets quality standards demanded by pharmaceutical research and development, clinical trials, and reference laboratories. Feedback and direct cooperation with formulation teams shape our constant improvements, especially when striving for lot-to-lot consistency and minimal impurities. Our batch records reflect patient care from synthesis to packaging.
Most labs searching for Tacrine Hydrochloride look for a product that stays reliable, not just on a certificate but through months of storage and under various conditions. Decades spent manufacturing this compound taught us that attention to subtle details in handling, purification, and storage conditions pays off. Some chemists might focus their scrutiny on melting point or solubility; others request repeatability in analytical results. As a manufacturer, we do not cut corners. Every step undergoes validation to ensure profiles remain steady.
At the core, Tacrine Hydrochloride combines a tetrahydroaminoacridine structure with hydrochloride, supporting improved stability in solution and solid phase. This stability matters if you are scaling from bench-top testing to animal studies or working towards full-scale formulation for clinical evaluation. Our synthesis routes rely on high-purity intermediates, stringent reaction monitoring, and robust crystallization stages. These steps lower the number of detectable impurities, which is why our lots repeatedly pass HPLC and NMR checks.
Many researchers raise concerns about batch purity. Impurity profiles can influence observed biological results, so we tune our filtration and recrystallization steps. Years ago, feedback from a drug development partner helped us pinpoint minor isomeric impurities overlooked by typical screens. Adapting our in-process controls at crystallization allowed us to raise the bar across subsequent batches. The current process regularly produces Tacrine Hydrochloride with purity above 99%, backed by multiple orthogonal analyses.
We have used both open-column and preparative chromatographic cleanups depending on the scale and quality requirements. Modern NMR, MS, and advanced LC detectors ensure our documentation stays comprehensive. Some years, variability in upstream raw materials taught us to build more redundancy into supply chains, so that our output remains stable throughout the year.
Tacrine Hydrochloride stands out from other cholinesterase inhibitors, not just because it was among the earlier agents studied for cognitive disorders, but also owing to its distinct structure and pharmacokinetics. From a manufacturing point of view, its synthesis brings a unique set of requirements due to its sensitivity to oxidation and trace catalysis during certain reaction stages. Unlike donepezil or rivastigmine, Tacrine often requires robust antioxidant protection post-synthesis.
Physicians and researchers often compare Tacrine to more recent inhibitors, noting differing spectra of action and tolerability. Manufacturing highlights a different set of contrasts. For example, donepezil or galantamine often come as crystalline solids with relatively straightforward handling, but Tacrine Hydrochloride has hygroscopic properties. Many customers seek granular control over moisture levels in each shipment, prompting us to adopt vacuum-packing and sealed aluminum containers as standard.
Storage stability, not shelf-life on paper, but actual substance integrity, becomes a testing ground here. Samples shipped overseas have faced wide temperature swings, encouraging us to audit our logistics partners and packaging solutions. We maintain environmental monitoring both in-house and through distribution, so end users rely on a product that resists degradation through transit.
Most orders for Tacrine Hydrochloride come from research teams focused on neurodegenerative disease pathways. Requests arrive for both in vitro and in vivo use; sometimes at the milligram scale for screening, other times in larger quantities for formulation attempts. Our extensive documentation simplifies regulatory submission for non-clinical and clinical studies, as all analytical and manufacturing data stay available for audit.
Some years ago, a university team reached out to track minor technical issues encountered during dissolution studies. By collaborating directly, we helped them refine their method to better match the solvation characteristics of our product, removing ambiguity from their results. These partnerships create learning opportunities that help both sides improve standards and validate best practices.
Tacrine Hydrochloride’s long-standing role in memory impairment research keeps it on the radar for teams exploring alternative delivery forms or repurposing. Demand sometimes shifts beyond academia; contract research organizations request tailored packaging or blinding for controlled trial settings.
All material departing our plant ships with documentation reflecting real analytical work. We match COAs with batch samples, and wherever possible, share full chromatograms for customer review. Peer review and reproducibility in science both depend on these touchpoints of reliability.
Over years, our main Tacrine Hydrochloride output comes as a white to off-white crystalline powder, hydrochloride salt, and meets a tightly defined purity threshold set by current pharmacopoeias, as well as stricter internal benchmarks. Package sizes range from research-oriented vials to bulk supply for scale-up. One thing that often separates real-world manufacturing from catalog listings is the capacity to flex for nonstandard orders. Some clients need unusually fine powder, while others specify a different water content window due to application concerns.
We have responded to these niche demands by adding sieving or additional drying steps during preparation. For teams with highly specialized requirements, we prepare dedicated lots—process-segregated and tested against custom standards, sometimes adding extended analytics such as water activity or specific isomer ratios. With all that, traceability stays complete back to initial reagent batches.
Analytical testing combines UV-Vis, HPLC, Karl Fischer titration, and in some batches, gas chromatography. By using direct feedback from quality control laboratories, we have learned which data matter most to different industries and modify our protocols accordingly.
We learned that rigorous, on-site quality oversight cannot be rushed. Each step of Tacrine Hydrochloride production—from raw material intake through reaction, distillation, isolation, and drying—benefits from direct supervision. Our chemists keep eyes and hands on every batch, logging yields, color, and clarity at each transfer.
Data rarely tells the whole story alone. Human experience supplements instruments, especially when evaluating crystallinity or detecting subtle off-odors. We require dual validation of each batch before release, combining instrument-based quantification with senior chemist signoff. Decades watching process drifts from environmental factors taught us to double-check all line cleaning and monitor cross-contamination with regular environmental swabs.
Beyond environmental and machine monitoring, we run regular proficiency evaluations where samples from each shift are tested independently and blind by different analysts. Any batch that falls outside agreed-upon specification ranges triggers a full process review. Benchmarking against internal and external standards sharpens our understanding and highlights which variables most influence material characteristics.
Every shipment and feedback cycle pushes us to finer standards. One story comes to mind involving a government lab adjusting flow rates for new animal trials. They noticed inconsistent response curves in some runs, traced back to carrier solvents interacting differently with our salt than those from another supplier. Working closely, we learned more about how minor shifts in salt form—crystal habit, lattice water—could play a part in kinetics and solubility. We shifted upstream drying and sieving steps, monitored results, and found improvements not just on our end, but in the predictability of their research outcomes.
Years spent listening to researchers and formulation scientists led us to broaden batch analytics beyond minimal regulatory requirements. Many regulatory filings hinge on transparency—knowing what’s in each bottle, whether shipped locally or exported. Our documentation logs batch-level contaminants, trace solvents, residual metals, and anything else partners might need to clear due diligence.
Frequent retesting and cross-checking with customer laboratories bring in valuable checks and new perspectives. Sometimes, feedback uncovers obscure interactions or analytical cross-reactivity, which guides process tweaks that flow back into routine production.
Producing Tacrine Hydrochloride at scale surfaces several hurdles: impurity minimization, managing hygroscopicity, ensuring lot uniformity across seasons, and maintaining full regulatory traceability. Oxidation and hydrolysis can degrade product quality if not handled quickly after synthesis. Early in process development, we set up controlled atmosphere workspaces during isolation, which improved long-term stability and reduced batch-to-batch variability.
Maintaining rigorous cleaning protocols between product runs remains another ongoing commitment. Trace amounts of residual byproducts from previous syntheses, if left unchecked, can compromise sensitive applications. The cleaning process goes beyond standard solvent flushing; it employs test swabs and targeted spectroscopic controls. Training and reinforcing good habits matter as much as hardware upgrades.
Shipping generates challenges most catalog readers never see. Deliveries to climates where humidity and heat hit high extremes test even robust packaging. We have invested in double-sealed drum liners and moisture-indicator labels. Each consignment undergoes confirmation weighing and random re-testing upon arrival to final destinations, so end users never wonder about real water content or possible degradation.
Close involvement from concept to drum lets us spot potential pitfalls before our product lands in a customer’s hands. Distance from distribution or catalog sales means long waiting times if questions arise. By staying engaged with all segments, we answer technical queries fast and provide documentation in response to real needs—not just generic templates.
A few years ago, a series of requests piled in from a consortium involved in comparative studies between different supplier lots. Some batches showed unexplained drift in biological activity. Directly comparing their findings with our batch-level analytics, we identified a minor solvent impurity not previously tracked. Updating our process to screen for this trace component immediately reassured the consortium’s researchers and informed our approach for all subsequent product lots.
Our direct manufacturing and technical support team know the backstory of each product batch. This depth of knowledge lets us guide customers on shelf life, storage, and solubility considerations under laboratory or industrial conditions. If questions arise over photostability or solvent compatibility, we respond with test data from actual production, not just literature references.
Process safety and environmental protection form another foundation of our operation. Production of Tacrine Hydrochloride involves chemicals that, mishandled, present risks to both workers and environment. We upgrade process ventilation, personal protective equipment, and waste management in response to global safety standards. Our waste water treatment system incorporates real-time monitoring and periodic external audits. These investments mean all steps—from synthesis to drying—reduce emissions and prevent contaminant leaks.
Waste management extends to packaging materials. By substituting unnecessary plastics with recyclable liners and engaging in manufacturer take-back programs, we lowered our environmental footprint. Regular staff training and annual safety drills keep vigilance sharp. These disciplines maintain not just compliance, but long-term staff health and community stewardship.
By linking process changes to metrics—reduced solvent volumes, air quality improvements, and low worker incident rates—we see real payoffs beyond basic regulatory compliance. Over time, experience confirms this direct attention pays dividends in safety, quality, and trust.
Pharmaceutical, clinical, and academic labs steer innovation by designing and interpreting studies, but their successes depend partly on raw material quality and reliability. Manufacturing Tacrine Hydrochloride with care, transparency, and honest data helps these projects move faster from idea to validated result.
We remind research and manufacturing partners: open dialogue improves outcomes for all. As Tacrine Hydrochloride remains a staple reference compound and active pharmaceutical ingredient, the shared goal always lies not just in meeting paperwork or filling catalog orders, but in delivering real, fit-for-purpose material every time.
We welcome outreach from those working at the frontier of cognitive research, reference standard generation, or advanced formulation science, knowing that our dedication to quality and openness underpins better science and, ultimately, improved patient care.